Sneaky Midsole Pen - Trainer Sneaker Touch Up Marker Paint Pen

Product Information

For more information on the use of adrenaline auto-injectors in schools, see Auto Injectors in Schools - More information can be found in Class 2 Medicines Recall: Emerade 300 micrograms solution for injection in pre-filled syringe, PL 33616/0014 (EL(20)A/20). Information on Emerade 500 microgram auto-injectors This is a recall for Emerade 300 microgram pens only. This is a different alert to that issued on 4 March 2020 for Emerade 150 microgram auto-injectors.

There are two types of AAIs available in the UK, these are called Epi-Pen and Jext. They both contain the same type of medication called ‘adrenaline’ (also referred to as ‘epinephrine’) which is given by injection, into the outer midthigh muscle. AAIs are prescription only medicines, and need to be prescribed by a healthcare professional –usually your GP or allergy specialist. The dose of adrenaline required is dependent on the age and weight of the person requiring the AAI device, and will be prescribed by the doctor. It is important that AAIs prescribed for children are reviewed as they get older and increase in weight to ensure they have the correct dose. Each AAI device will differ in appearance and the availability of the dose/strength available in that particular brand. Results from manufacturer testing of Emerade auto-injectors recalled from patients in Europe indicate that approximately 13% of pens need higher than normal force to activate, implying a higher risk of activation failure than was previously understood. This applies to all strengths of Emerade.Adrenaline is the first line of treatment for serious allergic reactions (anaphylaxis). It is available on prescription in a pre-loaded injection device (known as an adrenaline auto-injector or AAI). For Emerade 150 micrograms auto-injectors, the MHRA, in conjunction with the Department of Health & Social Care (DHSC) has established that there are sufficient supplies of alternative auto-injectors to allow for a recall to patient level. General Practitioners (GPs) should send the attached Patient Letter – Advice for patients with an Emerade 150 microgram auto-injector to all patients and carers, as appropriate, who have been prescribed Emerade 150 micrograms auto-injectors. use a second adrenaline auto-injector immediately if an Emerade pen fails to activate despite pressing firmly against the thigh, see Class 2 Medicines Recall: Emerade 150 micrograms solution for injection in pre-filled syringe, PL 33616/0013 (EL(20)A/14) for pictorial guidance; administer an adrenaline auto-injector device without delay, even if there is doubt whether it is anaphylaxis;

EpiPen ®Jr(adrenaline)Auto-Injector0.15mgSummaryofProductCharacteristics.Availableat: https://www.medicines.org.uk/ Patients with Emerade 150 microgram auto-injectors should be provided with the supplementary letter and information (see Patient Letter – Advice for patients with an Emerade 150 microgram auto-injector) All patients should be made aware of the signs and symptoms of anaphylaxis and that at the first onset of any signs or symptoms of anaphylaxis, they or a carer/bystander should: are aware that this recall also applies to Emerade 300 microgram auto-injectors that are in emergency anaphylaxis kits held by healthcare professionals, such as dental surgery kits etc. NICE Anaphylaxis Guidelines. Available at https://www.nice.org.uk/guidance/cg134/evidence/anaphylaxis-full-guideline-pdf-184946941. Last Accessed: May 2023

Viatris Connect

Always have your AAI with you at all times. If you need to use it, always call 999 for an ambulance telling the call handler it is ‘anaphylaxis’ so they can prioritise the response. inform patients to return Emerade 300 microgram auto-injectors to the pharmacy, when they have obtained two adrenaline auto-injectors in a different brand; General Practitioners (GPs) should send the attached letter “Advice for patients who have been prescribed an Emerade 300 microgram auto-injector” in the document attached below, to all patients and carers, as appropriate, who have been prescribed Emerade 300 micrograms auto-injectors. Information in relation to Coronavirus (COVID-19):